摘要
乳腺增生性疾病发病机制尚不清楚,临床诊断、治疗标准尚缺乏共识,对其可能发生癌变的临床特点和规律认识仍不清楚,对疾病进展缺乏有效的临床监测方法。乳腺纤维腺瘤外科治疗中如何关注到病人美观问题,需要探索微小纤维腺瘤的处理原则和微创手术方法,乳腺纤维腺瘤病的预防和治疗仍然存在困难。聚丙烯酰胺水凝胶类注射式隆乳后发生的哺乳期急性乳腺炎发病和治疗方法具有特殊性,而浆细胞性乳腺炎的治疗方法尚未达成共识。乳腺癌前病变的诊断和临床检测方法和乳腺原位癌的治疗仍须进一步深入研究。努力探索解决这些临床问题的方法是进一步提高乳腺良性疾病治疗效果的关键。
Pathogenic mechanism leading to breast hyperplasia is still unclear, the standard of clinical diagnosis and treatment have not come to a consensus, the clinical characteristic and process of carcinogenesis from hyperplastic diseases of breast is unclear and there is short of effective clinical methods for monitoring the disease progression. In surgical management of breast fibroadenoma, how to obtain ideal cosmetic results needs to search for the principles of management and micro-invasive operation for micro-fibroadenoma. Difficulties still exist in prevention and treatment of breast fibroadenomas. The development and treatment of acute mastitis during lactation relating to polyacrylamide gel injection for breast augmentation have their specificities. And there is a lack of consensus on the treatment of plasma cell mastitis. Further and deeper study is still required for clinical detection and diagnosis of precancerous lesion and breast cancer in situ. The key of raising the therapeutic effect in treating benign breast lesions is to make efforts to explore methods solving theseproblems.
出处
《中国实用外科杂志》
CSCD
北大核心
2009年第3期196-198,共3页
Chinese Journal of Practical Surgery
关键词
乳腺良性疾病
癌前病变
benign breast disease
precancerous lesions
